Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Maryam S. Alowayesh"'
Autor:
Maryam S. Alowayesh, Syed Mohamed Aljunid, Afaf Aladsani, Thamer Alessa, Abdulnabi Alattar, Dherar Alroudhan
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
Diabetes is known to compromise patients' health-related quality of life (HRQoL). It is important to understand the HRQoL of Kuwaiti nationals living with diabetes and identify factors that negatively affect it. This study included 1,182 Kuwaiti nati
Externí odkaz:
https://doaj.org/article/fbef0976a4e44a08b34b90fb15faf5bb
Autor:
Maryam S. Alowayesh, Syed M. Aljunid, Afaf Al-Adsani, Thamer Alessa, Abdulnabi Alattar, Dherar Alroudhan
Publikováno v:
PLoS ONE, Vol 17, Iss 6 (2022)
Background Diabetes imposes a large burden on countries’ healthcare expenditures. In Kuwait, diabetes prevalence in adults is estimated at 22.0%%—double the worldwide prevalence (9.3%). There is little current data on pharmaceutical costs in Kuwa
Externí odkaz:
https://doaj.org/article/7dace8c6a0354a8f9da4b4d0a0c87066
Autor:
Ahmad Fasseeh, Rita Karam, Mouna Jameleddine, Mohsen George, Finn Børlum Kristensen, Abeer A. Al-Rabayah, Abdulaziz H. Alsaggabi, Maha El Rabbat, Maryam S. Alowayesh, Julia Chamova, Adham Ismail, Sherif Abaza, Zoltán Kaló
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
IntroductionImplementation of health technology assessment (HTA) is still in an early stage with some heterogeneity in the Middle East and North Africa (MENA). Our objective was to assess the current and future status of HTA implementation in the MEN
Externí odkaz:
https://doaj.org/article/5e60a383b2fd43ad8992538755ec03b0
Autor:
Ahmad Fasseeh, Rita Karam, Mouna Jameleddine, Mohsen George, Finn Børlum Kristensen, Abeer A. Al-Rabayah, Abdulaziz H. Alsaggabi, Maha El Rabbat, Maryam S. Alowayesh, Julia Chamova, Adham Ismail, Sherif Abaza, Zoltán Kaló
Publikováno v:
Fasseeh, A, Karam, R, Jameleddine, M, George, M, Kristensen, F B, Al-Rabayah, A A, Alsaggabi, A H, El Rabbat, M, Alowayesh, M S, Chamova, J, Ismail, A, Abaza, S & Kaló, Z 2020, ' Implementation of Health Technology Assessment in the Middle East and North Africa : Comparison Between the Current and Preferred Status ', Frontiers in Pharmacology, vol. 11, 15 . https://doi.org/10.3389/fphar.2020.00015
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2020)
Introduction: Implementation of health technology assessment (HTA) is still in an early stage with some heterogeneity in the Middle East and North Africa (MENA). Our objective was to assess the current and future status of HTA implementation in the M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06c1c9caaf2562290731c9f3fbfcbd3a
https://findresearcher.sdu.dk:8443/ws/files/168459027/fphar_11_00015.pdf
https://findresearcher.sdu.dk:8443/ws/files/168459027/fphar_11_00015.pdf
Autor:
Raed Alroughani, Raed Behbehani, Samar Farouk Ahmed, Maryam S. Alowayesh, Jasem Yousef Al-Hashel
Publikováno v:
Neurology. 90:e840-e846
ObjectiveTo determine the rate of relapse occurrence during pregnancy and postpartum.MethodsIn a cross-sectional study using the national multiple sclerosis (MS) registry, pregnant women with relapsing MS were identified. Data on demographics, clinic
Autor:
Maryam Al-Hussaini, Anke-Peggy Holtorf, Maryam S. Alowayesh, Jacinthe Lemay, Ali Hadi Abdullah, Zoltán Kaló
Publikováno v:
Journal of Pharmaceutical Policy and Practice
Journal of Pharmaceutical Policy and Practice, Vol 12, Iss 1, Pp 1-7 (2019)
Journal of Pharmaceutical Policy and Practice, Vol 12, Iss 1, Pp 1-7 (2019)
Background In Kuwait, the government is planning to improve the specifications for purchase of medicine and to improve the tendering system intending to slow the growth of the expenditure for medicine and to improve the sustainability of the healthca
Autor:
Maryam S. Alowayesh, Rita Karam, A.N. Fasseeh, M. George, S. Abaza, M. Jameleddine, Julia Chamova, A.A. Al Rabayah, A.R.I.A. Moneim, Finn Børlum Kristensen, Abdulaziz H Al-Saggabi, M. El Rabbat, Z. Kalo
Publikováno v:
Value in Health. 22:S315-S316
Autor:
Zoltán Kaló, Panos Kanavos, Ola Ghaleb Al Ahdab, Abdulaziz H Al-Saggabi, Zoltán Vokó, Hamad S Alsultan, Maryam S. Alowayesh, Vito Luigi Tanzi, Faleh Mohamed Hussain Ali, Ibrahim Alabbadi, Mahmoud Elmahdawy, Kasem S Akhras, Gihan Hamdy Elsisi, Daoud Al-Badriyeh
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 15:993-998
Introduction: External price referencing (EPR) is applied frequently to control pharmaceutical prices. Our objective was to analyse how EPR is used in Middle Eastern (ME) countries and to compare the price corridor for original pharmaceuticals to non
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 5, p e0216646 (2019)
PLoS ONE, Vol 14, Iss 5, p e0216646 (2019)
BackgroundMultiple Sclerosis (MS) is a chronic neurological disease with heavy economic and social burdens resulting in significant disability.ObjectiveThis study aims to (1) measure the cost of health resources utilization by MS patients and (2) to
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Background Chronic spontaneous urticaria (CSU) is a common problem worldwide. We evaluated the direct medical costs of treating patients with refractory CSU and the budget effect of omalizumab use in these patients in Kuwait. Methods The prevalence o